Monthly Archives: August 2026
- - August 21, 2026
Two substances now common in the illicit opioid supply do not appear on a standard point-of-care panel. What the CDC advisory on medetomidine and the June carfentanil data mean for programs running required random drug testing.
- - August 15, 2026
Returned meds, sharps and red-bag waste share one loading dock but answer to three different regulators — the DEA, OSHA and DOT. Here's where facilities actually get caught: not the stream they hold a contract for, but the one still running on habit.
- - August 03, 2026
For most opioid treatment programs, 2026 is shaping up to be a year of doing the same work with a budget that isn't growing. In its FY2026 request, the federal government proposed folding the three main behavioral-health block grants — community mental health, substance use prevention and treatment, and state opioid response — into a single Behavioral Health Innovation Block Grant that comes in roughly $500 million below the combined total of the programs it replaces. Direct opioid-treatment-program funding is held flat, and proposed Medicaid reductions add pressure on the reimbursement side. Set the politics aside; the operational takeaway is simple. The money to run your program is, at best, holding steady while everything around it costs more.
At Med Supply Lab, we make our own take-home dosing bottles, child-resistant lids, and dosing cups, and we sell to opioid treatment programs — so we spend our days on the supply side of exactly this problem. When budgets tighten, procurement gets
